Key Takeaways
- South32 (S32) has agreed to sell its aluminium value chain assets to Alcoa (AA) for up to $5.6 billion, with Alcoa assuming $1.2 billion in rehabilitation provisions.
- Switzerland's Real Retail Sales surged 3.5% year-on-year in May, significantly outperforming the previous month's 1.7% growth and market estimates.
- Sweden’s Manufacturing PMI climbed to 58.3 in June, marking its highest level since early 2022 and signaling robust industrial expansion.
- UK House Prices rose 2.2% year-on-year in June, though monthly growth remained flat at 0.0% as high interest rates continue to temper market momentum.
- U.S. Lawmakers launched a bipartisan investigation into Merck & Co. (MRK) and AbbVie (ABBV) regarding their clinical drug trial activities in China.
Industrial and Retail Momentum in Europe
The European economic landscape showed signs of strengthening on Wednesday. Sweden’s Swedbank/SILF Manufacturing PMI reached 58.3 in June, up from 57.3 in May, continuing a trend of expansion that has now lasted nearly a year. This reading reflects strong production levels and employment growth within the Swedish industrial sector, which remains a top performer among international peers.
In Switzerland, consumer activity provided a major upside surprise. Real Retail Sales grew by 3.5% in May compared to the previous year, more than doubling the 1.7% growth recorded in April. The data suggests resilient domestic demand despite broader European inflationary pressures, providing a positive signal for the Swiss economy heading into the second half of the year.
Corporate Strategy and Regulatory Headwinds
South32 (S32) announced a transformative deal to offload its aluminium assets to Alcoa (AA) for an enterprise value of $5.6 billion. The transaction includes $3.1 billion in upfront cash and $1.0 billion in Alcoa shares. Crucially, Alcoa will take over $1.2 billion in long-term rehabilitation liabilities, allowing South32 to pivot toward base metals like copper and zinc while targeting $125 million in annual overhead savings.
Simultaneously, the pharmaceutical sector faces renewed political scrutiny in Washington. U.S. lawmakers have initiated an investigation into Merck & Co. (MRK), AbbVie (ABBV), Pfizer (PFE), Eli Lilly (LLY), and Bristol Myers Squibb (BMY). The probe focuses on clinical trials conducted in collaboration with Chinese military hospitals and facilities in the Xinjiang region, citing potential risks to intellectual property and national security.
Real Estate and Central Bank Outlook
The UK housing market showed modest recovery as Nationwide reported annual house price growth of 2.2% for June. While this is an improvement over May’s 1.7%, the month-on-month figure was flat at 0.0%, missing expectations of a 0.1% rise. Analysts suggest that while affordability remains a challenge, a recent softening in mortgage rates could support a recovery in the coming quarters.
Global markets are now turning their attention to the ECB Forum on Central Banking in Sintra. A high-stakes policy panel featuring Fed Chair Kevin Warsh, ECB President Christine Lagarde, BoE Governor Andrew Bailey, and BoC Governor Tiff Macklem is scheduled for 2:00 PM BST. Investors are looking for clues on the future path of interest rates, particularly as Russia’s Manufacturing PMI returned to expansion territory at 50.3 in June, highlighting shifting global economic dynamics.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.